Literature DB >> 21431965

Advantages and disadvantages of the Amplatzer Vascular Plug IV in visceral embolization: report of 50 placements.

Maciej Pech1, Konrad Mohnike, Gero Wieners, Ricarda Seidensticker, Max Seidensticker, Adam Zapasnik, Jens Ricke, Oliver Dudeck.   

Abstract

PURPOSE: We describe our initial clinical experience in artificial embolization with the Amplatzer Vascular Plug IV (VP IV), a further development of the Vascular Plug family already in routine use.
METHODS: Results from 50 embolization procedures conducted with the VP IV in 44 patients are summarized.
RESULTS: All 50 embolizations were successful, although two required the technique to be modified because of problems with jamming of the screw thread and thus with disconnection of the plug. This was associated with large branching angles.
CONCLUSIONS: With experience, the VP IV can be used safely and effectively, and it expands the spectrum of possible embolizations in interventional radiology. Its greatest disadvantage is its relatively poor positional controllability.

Entities:  

Mesh:

Year:  2011        PMID: 21431965     DOI: 10.1007/s00270-011-0150-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

Review 1.  The Amplatzer Vascular Plug: Review of Evolution and Current Applications.

Authors:  Jorge E Lopera
Journal:  Semin Intervent Radiol       Date:  2015-12       Impact factor: 1.513

2.  Transcatheter closure of abnormal vessels and arteriovenous fistulas with the Amplatzer vascular plug 4 in patients with congenital heart disease.

Authors:  Gesa Wiegand; Ludger Sieverding; Wolfgang Bocksch; Michael Hofbeck
Journal:  Pediatr Cardiol       Date:  2013-04-17       Impact factor: 1.655

3.  Impact of site of occlusion in proximal splenic artery embolisation for blunt splenic trauma.

Authors:  A Boscà-Ramon; L Ratnam; T Cavenagh; J-Y Chun; R Morgan; M Gonsalves; R Das; S Ameli-Renani; V Pavlidis; B Hawthorn; N Ntagiantas; L Mailli
Journal:  CVIR Endovasc       Date:  2022-08-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.